Meier NT et al. (2013), Thyrotropin-releasing hormone (TRH) promotes wo...

XB-ART-47910

PLoS One 2013 Jan 01;89:e73596. doi: 10.1371/journal.pone.0073596.

Show Gene links Show Anatomy links

Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skin.

Meier NT , Haslam IS , Pattwell DM , Zhang GY , Emelianov V , Paredes R , Debus S , Augustin M , Funk W , Amaya E , Kloepper JE , Hardman MJ , Paus R .

???displayArticle.abstract???
There remains a critical need for new therapeutics that promote wound healing in patients suffering from chronic skin wounds. This is, in part, due to a shortage of simple, physiologically and clinically relevant test systems for investigating candidate agents. The skin of amphibians possesses a remarkable regenerative capacity, which remains insufficiently explored for clinical purposes. Combining comparative biology with a translational medicine approach, we report the development and application of a simple ex vivo frog (Xenopus tropicalis) skin organ culture system that permits exploration of the effects of amphibian skin-derived agents on re-epithelialisation in both frog and human skin. Using this amphibian model, we identify thyrotropin-releasing hormone (TRH) as a novel stimulant of epidermal regeneration. Moving to a complementary human ex vivo wounded skin assay, we demonstrate that the effects of TRH are conserved across the amphibian-mammalian divide: TRH stimulates wound closure and formation of neo-epidermis in organ-cultured human skin, accompanied by increased keratinocyte proliferation and wound healing-associated differentiation (cytokeratin 6 expression). Thus, TRH represents a novel, clinically relevant neuroendocrine wound repair promoter that deserves further exploration. These complementary frog and human skin ex vivo assays encourage a comparative biology approach in future wound healing research so as to facilitate the rapid identification and preclinical testing of novel, evolutionarily conserved, and clinically relevant wound healing promoters.

???displayArticle.pubmedLink??? 24023889
???displayArticle.pmcLink??? PMC3759422
???displayArticle.link??? PLoS One
???displayArticle.grants??? [+]

Species referenced: Xenopus tropicalis
Genes referenced: krt12.4 mki67 trh

???attribute.lit??? ???displayArticles.show???

	Figure 2. Frog serum and estrogen promote re-epithelialisation and proliferation in Xenopus tropicalis skin.(A) Representative images of re-epithelialisation sheet in control, 5% frog serum and 100 nM 17Î²-estradiol (Est)-treated punch wounds at day 7 in culture (scale bars: 0.5 mm). White-hatched lines indicate the leading edge of new epithelial sheets. (B) Representative images of PH3-positive cells in control, 5% frog serum and 100 nM 17Î²-estradiol-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. (C) Representative images of TUNEL-positive cells in control, 5% frog serum and 100 nM 17Î²-estradiol-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. Scale bars in (B) and (C) are 100 Âµm. (D) The graph shows the percentage reduction in wound-area of Xenopus tropicalis punch wounds in control, 5% frog serum (FS) and 100 nM 17Î²-estradiol-treated skin. (E) Percentage of proliferative (PH3-positive) cells present in the new epithelial tongue during re-epithelialisation. (F) Percentage of apoptotic (TUNEL-positive) cells present in the new epithelial tongue during re-epithelialisation. Data are mean Â± SEM of 4â5 frogs (2 male and 3 female). Significance relative to control data at the same time-point denoted by P<0.05, P<0.01, **P<0.001.
	Figure 3. Xenopus tropicalis wound closure: promotion of re-epithelialisation and proliferation by TRH.(A) Representative images of the re-epithelialisation sheet in control, 10 nM and 10 ÂµM TRH-treated punch wounds at day 7 in culture (scale bars: 0.5 mm). White-hatched lines indicate the leading edge of new epithelial sheets. (B) Representative images of PH3-positive cells in control, 10 nM and 10 ÂµM TRH-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. (C) Representative images of TUNEL-positive cells in control, 10 nM and 10 ÂµM TRH-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. Scale bars in (B) and (C) are 100 Âµm. (D) The graph shows the percentage reduction in wound-area of X. tropicalis punch wounds in control, 10 nM and 10 ÂµM TRH-treated skin. (E) Percentage of proliferative (PH3-positive) cells present in the new epithelial tongue during re-epithelialisation. (F) Percentage of apoptotic (TUNEL-positive) cells present in the new epithelial tongue during re-epithelialisation. Data are mean Â± SEM of 16 frogs (8 male and 8 female). Significance relative to control data at the same time-point denoted by P<0.05, **P<0.001.
	Figure 4. Xenopus tropicalis mitosis: TRH increases epidermal mitosis.(AâC) Representative images of Weigertâs stained X. tropicalis epidermis with black arrows indicating mitotic cells. (D) The graph shows the percentage of mitotic figures identified by Weigertâs staining in the X. tropicalis epidermis. 200 nuclei were analysed per skin section, with 3 sections per animal counted. (E) The graph displays the total number of DAPI+ nuclei in the new epithelial tongues. Data are mean Â± SEM of 4 frogs (2 male and 2 female). Significance relative to control data at the same time-point denoted by P<0.01, *P<0.001.
	Figure 5. Increased re-epithelialisation and proliferation in human skin following 17Î²-estradiol treatment.(A) Representative H&E stained sections of human skin punch-wounds following 6 days culture with either vehicle control, 100 nM or 1 ÂµM 17Î²-estradiol (Est). New epithelial tongue indicated by red lines, scale bar represents 50 Âµm. (B) Representative images of Ki-67-TUNEL double-stained sections of human skin punch wounds following 6 days culture with either vehicle control, 100 nM or 1 ÂµM 17Î²-estradiol. The white-hatched line demarcates new epithelial tongue. (C) The graph displays length measurements of the new epithelial tongue (as demarcated by the red lines in A) as analysed from H&E stained human skin sections following treatment with vehicle control, 100 nM and 1 ÂµM 17Î²-estradiol. (D) Percentage of proliferative (Ki67-positive) cells in the new epithelial tongue of vehicle control, 100 nM and 1 ÂµM 17Î²-estradiol-treated human skin wounds. (E) Percentage of apoptotic (TUNEL-positive) cells in the new epithelial tongue of vehicle control, 100 nM and 1 ÂµM 17Î² estradiol-treated human skin wounds. Data are mean Â± SEM of 4 female donors. Significance relative to control data denoted by P<0.05, P<0.01, **P<0.001.
	Figure 6. Cytokeratin 6 and Involucrin expression in human skin punch wounds following 17Î²-estradiol treatment.Representative images indicating cytokeratin 6 (CK6) expression in control, 100 nM and 1 ÂµM 17Î²-estradiol (Est)-treated human skin punch wound sections, 6 days post-wounding. The white-hatched line demarcates new epithelial tongue. (B) Representative images indicating involucrin (Inv) expression in control, 100 nM and 1 ÂµM 17Î²-estradiol-treated human skin punch wound sections, 6 days post-wounding. The white-hatched line demarcates new epithelial tongue. (C) Quantification of CK6 immunoreactivity in the new epithelial tongues indicated (A). (D) Quantification of involucrin immunoreactivity in the new epithelial tongues indicated in (B). Data are mean Â± SEM of 4 female donors. Significance relative to control data denoted by **P<0.01.
	Figure 7. TRH stimulates re-epithelialisation and enhances proliferation in wounded human skin.(A) Representative H&E stained sections of human skin punch-wounds following 6 days culture with either vehicle control or 10 ng/mL TRH. New epithelial tongues indicated by the white-hatched lines. Scale bars represent 50 Âµm. (B) Representative images of Ki-67-TUNEL double-stained sections of human skin punch wounds following 6 days culture with either vehicle control or 10 ng/mL TRH. The white-hatched line demarcates new epithelial tongue. (C) The graph displays length measurements of the new epithelial tongue (as demarcated by the white-hatched lines in A) as analysed from H&E stained human skin sections following treatment with vehicle control, 5 ng/mL and 10 ng/mL TRH. (D) Percentage of proliferative (Ki67-positive) cells in the new epithelial tongue of vehicle control, 5 ng/mL and 10 ng/mL TRH-treated human skin wounds. (E) Percentage of apoptotic (TUNEL-positive) cells in the new epithelial tongue of vehicle control, 5 ng/mL and 10 ng/mL TRH-treated human skin wounds. Data are mean Â± SEM of 4 female donors. Significance relative to control data at the same time-point denoted by P<0.05, P<0.01, **P<0.001.
	Figure 8. TRH increases cytokeratin 6 but not involucrin expression in human skin punch wounds.(A) Representative images indicated cytokeratin 6 (CK6) expression in control, 5 ng/mL and 10 ng/mL TRH-treated human skin punch wound sections, 6 Days post-wounding. The white-hatched line demarcates new epithelial tongue. (B) Representative images indicating involucrin (Inv) expression in control, 5 ng/mL and 10 ng/mL TRH-treated human skin punch wound sections, 6 Days post-wounding. The white-hatched line demarcates new epithelial tongue. (C) Quantification of involucrin immunoreactivity in the new epithelial tongues indicated in (A). (D) Quantification of CK6 immunoreactivity in the new epithelial tongues indicated in (B). Data are mean Â± SEM of 4 female donors. Significance relative to control data at the same time-point denoted by P<0.01, *P<0.001.

References [+] :

Alibardi, Morphological and cellular aspects of tail and limb regeneration in lizards. A model system with implications for tissue regeneration in mammals. 2010, Pubmed

	Figure 2. Frog serum and estrogen promote re-epithelialisation and proliferation in Xenopus tropicalis skin.(A) Representative images of re-epithelialisation sheet in control, 5% frog serum and 100 nM 17Î²-estradiol (Est)-treated punch wounds at day 7 in culture (scale bars: 0.5 mm). White-hatched lines indicate the leading edge of new epithelial sheets. (B) Representative images of PH3-positive cells in control, 5% frog serum and 100 nM 17Î²-estradiol-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. (C) Representative images of TUNEL-positive cells in control, 5% frog serum and 100 nM 17Î²-estradiol-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. Scale bars in (B) and (C) are 100 Âµm. (D) The graph shows the percentage reduction in wound-area of Xenopus tropicalis punch wounds in control, 5% frog serum (FS) and 100 nM 17Î²-estradiol-treated skin. (E) Percentage of proliferative (PH3-positive) cells present in the new epithelial tongue during re-epithelialisation. (F) Percentage of apoptotic (TUNEL-positive) cells present in the new epithelial tongue during re-epithelialisation. Data are mean Â± SEM of 4â5 frogs (2 male and 3 female). Significance relative to control data at the same time-point denoted by P<0.05, P<0.01, **P<0.001.
	Figure 3. Xenopus tropicalis wound closure: promotion of re-epithelialisation and proliferation by TRH.(A) Representative images of the re-epithelialisation sheet in control, 10 nM and 10 ÂµM TRH-treated punch wounds at day 7 in culture (scale bars: 0.5 mm). White-hatched lines indicate the leading edge of new epithelial sheets. (B) Representative images of PH3-positive cells in control, 10 nM and 10 ÂµM TRH-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. (C) Representative images of TUNEL-positive cells in control, 10 nM and 10 ÂµM TRH-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. Scale bars in (B) and (C) are 100 Âµm. (D) The graph shows the percentage reduction in wound-area of X. tropicalis punch wounds in control, 10 nM and 10 ÂµM TRH-treated skin. (E) Percentage of proliferative (PH3-positive) cells present in the new epithelial tongue during re-epithelialisation. (F) Percentage of apoptotic (TUNEL-positive) cells present in the new epithelial tongue during re-epithelialisation. Data are mean Â± SEM of 16 frogs (8 male and 8 female). Significance relative to control data at the same time-point denoted by P<0.05, **P<0.001.
	Figure 4. Xenopus tropicalis mitosis: TRH increases epidermal mitosis.(AâC) Representative images of Weigertâs stained X. tropicalis epidermis with black arrows indicating mitotic cells. (D) The graph shows the percentage of mitotic figures identified by Weigertâs staining in the X. tropicalis epidermis. 200 nuclei were analysed per skin section, with 3 sections per animal counted. (E) The graph displays the total number of DAPI+ nuclei in the new epithelial tongues. Data are mean Â± SEM of 4 frogs (2 male and 2 female). Significance relative to control data at the same time-point denoted by P<0.01, *P<0.001.
	Figure 5. Increased re-epithelialisation and proliferation in human skin following 17Î²-estradiol treatment.(A) Representative H&E stained sections of human skin punch-wounds following 6 days culture with either vehicle control, 100 nM or 1 ÂµM 17Î²-estradiol (Est). New epithelial tongue indicated by red lines, scale bar represents 50 Âµm. (B) Representative images of Ki-67-TUNEL double-stained sections of human skin punch wounds following 6 days culture with either vehicle control, 100 nM or 1 ÂµM 17Î²-estradiol. The white-hatched line demarcates new epithelial tongue. (C) The graph displays length measurements of the new epithelial tongue (as demarcated by the red lines in A) as analysed from H&E stained human skin sections following treatment with vehicle control, 100 nM and 1 ÂµM 17Î²-estradiol. (D) Percentage of proliferative (Ki67-positive) cells in the new epithelial tongue of vehicle control, 100 nM and 1 ÂµM 17Î²-estradiol-treated human skin wounds. (E) Percentage of apoptotic (TUNEL-positive) cells in the new epithelial tongue of vehicle control, 100 nM and 1 ÂµM 17Î² estradiol-treated human skin wounds. Data are mean Â± SEM of 4 female donors. Significance relative to control data denoted by P<0.05, P<0.01, **P<0.001.
	Figure 6. Cytokeratin 6 and Involucrin expression in human skin punch wounds following 17Î²-estradiol treatment.Representative images indicating cytokeratin 6 (CK6) expression in control, 100 nM and 1 ÂµM 17Î²-estradiol (Est)-treated human skin punch wound sections, 6 days post-wounding. The white-hatched line demarcates new epithelial tongue. (B) Representative images indicating involucrin (Inv) expression in control, 100 nM and 1 ÂµM 17Î²-estradiol-treated human skin punch wound sections, 6 days post-wounding. The white-hatched line demarcates new epithelial tongue. (C) Quantification of CK6 immunoreactivity in the new epithelial tongues indicated (A). (D) Quantification of involucrin immunoreactivity in the new epithelial tongues indicated in (B). Data are mean Â± SEM of 4 female donors. Significance relative to control data denoted by **P<0.01.
	Figure 7. TRH stimulates re-epithelialisation and enhances proliferation in wounded human skin.(A) Representative H&E stained sections of human skin punch-wounds following 6 days culture with either vehicle control or 10 ng/mL TRH. New epithelial tongues indicated by the white-hatched lines. Scale bars represent 50 Âµm. (B) Representative images of Ki-67-TUNEL double-stained sections of human skin punch wounds following 6 days culture with either vehicle control or 10 ng/mL TRH. The white-hatched line demarcates new epithelial tongue. (C) The graph displays length measurements of the new epithelial tongue (as demarcated by the white-hatched lines in A) as analysed from H&E stained human skin sections following treatment with vehicle control, 5 ng/mL and 10 ng/mL TRH. (D) Percentage of proliferative (Ki67-positive) cells in the new epithelial tongue of vehicle control, 5 ng/mL and 10 ng/mL TRH-treated human skin wounds. (E) Percentage of apoptotic (TUNEL-positive) cells in the new epithelial tongue of vehicle control, 5 ng/mL and 10 ng/mL TRH-treated human skin wounds. Data are mean Â± SEM of 4 female donors. Significance relative to control data at the same time-point denoted by P<0.05, P<0.01, **P<0.001.
	Figure 8. TRH increases cytokeratin 6 but not involucrin expression in human skin punch wounds.(A) Representative images indicated cytokeratin 6 (CK6) expression in control, 5 ng/mL and 10 ng/mL TRH-treated human skin punch wound sections, 6 Days post-wounding. The white-hatched line demarcates new epithelial tongue. (B) Representative images indicating involucrin (Inv) expression in control, 5 ng/mL and 10 ng/mL TRH-treated human skin punch wound sections, 6 Days post-wounding. The white-hatched line demarcates new epithelial tongue. (C) Quantification of involucrin immunoreactivity in the new epithelial tongues indicated in (A). (D) Quantification of CK6 immunoreactivity in the new epithelial tongues indicated in (B). Data are mean Â± SEM of 4 female donors. Significance relative to control data at the same time-point denoted by P<0.01, *P<0.001.